Oxidative stress and cognitive decline: the neuroprotective role of natural antioxidants

F Franzoni, G Scarfò, S Guidotti, J Fusi… - Frontiers in …, 2021 - frontiersin.org
Free-radicals (Oxygen and Nitrogen species) are formed in mitochondria during the
oxidative phosphorylation. Their high reactivity, due to not-engaged electrons, leads to an …

OxInflammation: from subclinical condition to pathological biomarker

G Valacchi, F Virgili, C Cervellati, A Pecorelli - Frontiers in physiology, 2018 - frontiersin.org
Inflammation is a complex systemic response evolved to cope with cellular injury, either due
to infectious agents or, in general, with sporadic events challenging tissue integrity and …

Rett syndrome: a neurological disorder with metabolic components

SM Kyle, N Vashi, MJ Justice - Open biology, 2018 - royalsocietypublishing.org
Rett syndrome (RTT) is a neurological disorder caused by mutations in the X-linked gene
methyl-CpG-binding protein 2 (MECP2), a ubiquitously expressed transcriptional regulator …

[HTML][HTML] Clinical and biological progress over 50 years in Rett syndrome

H Leonard, S Cobb, J Downs - Nature Reviews Neurology, 2017 - nature.com
In the 50 years since Andreas Rett first described the syndrome that came to bear his name,
and is now known to be caused by a mutation in the methyl-CpG-binding protein 2 (MECP2) …

The multifaceted role of mitochondria in autism spectrum disorder

I Khaliulin, W Hamoudi, H Amal - Molecular psychiatry, 2024 - nature.com
Normal brain functioning relies on high aerobic energy production provided by
mitochondria. Failure to supply a sufficient amount of energy, seen in different brain …

Complement system in brain architecture and neurodevelopmental disorders

J Magdalon, F Mansur, AL Teles e Silva… - Frontiers in …, 2020 - frontiersin.org
Current evidence indicates that certain immune molecules such as components of the
complement system are directly involved in neurobiological processes related to brain …

Treating Rett syndrome: from mouse models to human therapies

N Vashi, MJ Justice - Mammalian Genome, 2019 - Springer
Rare diseases are very difficult to study mechanistically and to develop therapies for
because of the scarcity of patients. Here, the rare neuro-metabolic disorder Rett syndrome …

Multifactorial origin of neurodevelopmental disorders: approaches to understanding complex etiologies

A De Felice, L Ricceri, A Venerosi, F Chiarotti… - Toxics, 2015 - mdpi.com
A significant body of evidence supports the multifactorial etiology of neurodevelopmental
disorders (NDDs) affecting children. The present review focuses on early exposure to …

RIPK1 activation in Mecp2-deficient microglia promotes inflammation and glutamate release in RTT

Z Cao, X Min, X Xie, M Huang, Y Liu… - Proceedings of the …, 2024 - National Acad Sciences
Rett syndrome (RTT) is a devastating neurodevelopmental disorder primarily caused by
mutations in the methyl-CpG binding protein 2 (Mecp2) gene. Here, we found that inhibition …

Mitochondrial dysfunction in the pathogenesis of Rett syndrome: implications for mitochondria-targeted therapies

N Shulyakova, AC Andreazza, LR Mills… - Frontiers in cellular …, 2017 - frontiersin.org
First described over 50 years ago, Rett syndrome (RTT) is a neurodevelopmental disorder
caused primarily by mutations of the X-linked MECP2 gene. RTT affects predominantly …